Prognostic factors for local recurrence in patients with rectal cancer submitted to neoadjuvant chemoradiotherapy and total mesorectal excision
Author:
Nahas Caio Sergio Rizkallah,
Nahas Sergio CarlosORCID,
Marques Carlos Frederico SparapanORCID,
Ribeiro Junior Ulysses,
Bustamante-Lopez LeonardoORCID,
Cotti Guilherme Cutait,
Imperiale Antonio RoccoORCID,
Pinto Rodrigo AmbarORCID,
Cecconello Ivan
Reference32 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018
2. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Glynne-Jones;Ann Oncol,2017
3. MERCURY study group. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study;Taylor;Ann Surg.,2011
4. MRI for detection of extramural vascular invasion in rectal cancer;Smith;AJR Am J Roentgenol,2008
5. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience;Patel;J Clin Oncol,2011